Olympus Co. (OTCMKTS:OLYMY) Sees Significant Decline in Short Interest

Olympus Co. (OTCMKTS:OLYMYGet Free Report) saw a significant decline in short interest in the month of May. As of May 29th, there was short interest totaling 39,080 shares, a decline of 39.6% from the May 14th total of 64,672 shares. Based on an average daily trading volume, of 185,604 shares, the days-to-cover ratio is presently 0.2 days.

Olympus Trading Down 0.1%

Shares of OTCMKTS OLYMY opened at $10.35 on Wednesday. Olympus has a 52-week low of $8.08 and a 52-week high of $13.73. The stock has a 50 day moving average price of $10.60 and a 200 day moving average price of $11.07.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group downgraded shares of Olympus from a “buy” rating to a “neutral” rating in a research note on Monday. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Olympus has an average rating of “Hold”.

Read Our Latest Analysis on OLYMY

About Olympus

(Get Free Report)

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.

Recommended Stories

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.